Research Article
Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide
Figure 1
The results of receiver operating characteristic curve analyses. (a) Progression-free survival. (b) Overall survival.
(a) |
(b) |